TWL Holdings Bhd logo

TWL Holdings Bhd (7079)

Market Closed
11 Aug, 07:45
XKLS XKLS
RM
0. 03
+0.01
+25%
RM
- Market Cap
- P/E Ratio
380% Div Yield
10.43M Volume
- Eps
RM 0.02
Previous Close
Add Transaction
Day Range
0.02 0.03
Year Range
0.02 0.03
Want to track 7079 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

7079 closed today higher at RM0.03, an increase of 25% from yesterday's close, completing a monthly increase of 0% or RM0. Over the past 12 months, 7079 stock gained 25%.
7079 is not paying dividends to its shareholders.
The last earnings report, released on Dec 31, 2016, missed the consensus estimates by -0.0015%. On average, the company has surpassed earnings expectations by 0.0003%, based on the last three reports.
TWL Holdings Bhd has completed 5 stock splits, with the recent split occurring on Sep 08, 2021.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on JPX (JPY).

7079 Chart

TWL Holdings Bhd (7079) FAQ

What is the stock price today?

The current price is RM0.03.

On which exchange is it traded?

TWL Holdings Bhd is listed on XKLS.

What is its stock symbol?

The ticker symbol is 7079.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 380%.

What is its market cap?

As of today, no market cap data is available.

Has TWL Holdings Bhd ever had a stock split?

TWL Holdings Bhd had 5 splits and the recent split was on Sep 08, 2021.

TWL Holdings Bhd Profile

Insurance Industry
Financials Sector
Mr. Haruhiko Taniguchi CEO
XKLS Exchange
MYL7079OO006 ISIN
Japan Country
566 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

WDB coco Co., Ltd., established in 1984, operates from its headquarters in Tokyo, Japan, offering comprehensive contract services to the pharmaceutical sector. The company specializes in aiding the development of pharmaceuticals and medical devices by focusing primarily on safety information management and support. Its clientele mainly includes pharmaceutical companies located within Japan. WDB coco Co., Ltd. prides itself on its extensive support network for clinical research, post-marketing safety, and regulatory compliance, ensuring its clients can navigate the challenging pharmaceutical landscape efficiently and effectively.

Products and Services

  • Safety Information Management and Support - Offers critical services that focus on the collection, analysis, and reporting of safety data for pharmaceuticals and medical devices. This includes monitoring adverse events, ensuring compliance with global regulatory requirements, and implementing safety protocols.
  • Clinical Research Support - Provides comprehensive assistance in clinical trials, including project management, monitoring, patient recruitment, and data analysis. The goal is to facilitate the smooth operation of trials, ensuring they are conducted efficiently and in accordance with ethical standards.
  • Post-marketing Safety Information Management Operations - Engages in activities related to the surveillance of products after they have been launched in the market. This includes gathering and evaluating safety information to ensure ongoing compliance and to identify any emerging risks or trends.
  • Translation and QC Support - Offers translation services for clinical research documentation, regulatory submissions, and other critical materials. Additionally, provides quality control (QC) services to ensure accuracy and compliance of translated materials.
  • Manpower Dispatch Services - Supplies skilled professionals to support various phases of pharmaceutical development and post-marketing activities. This includes providing temporary staffing solutions for projects that require specialized knowledge or skills.
  • Post-Marketing Surveillance (PMS) Services - Delivers end-to-end support for post-marketing surveillance studies. Services include contracting with medical facilities, explaining studies, managing survey forms, monitoring, and re-survey activities, registering cases, data management, and conducting statistical analysis. This comprehensive approach aids in tracking the long-term effectiveness and safety of pharmaceutical products.

Contact Information

Address: Triton Square Y
Phone: 81 3 5144 2250